
MS: Polpharma joins forces with Sandoz
Natalizumab, which is currently being marketed by Biogen, is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is a...

Creoptix AG closes CHF8m financing round
The financing round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation as well as existing private investors....

EMA greenlights new medicines
With the three innovative medicines and four generics the number of recommended medicines raised to 47 in 2019. The Committee saw a positive...

Update: BIO-Europe growing further
According to still official figures, EBD Group's partnering event in Hamburg, the vibrant centre of Life Science Nord's life science cluster, hit a...

Azeria Therapeutics bags €37.3m in Series B financing round
Series A lead investor CRT Pioneer Fund co-financed the Series B financing round. Azeria said it will use the proceeds to develop its preclinical...

European circular bioeconomy fund near closing
Hauck & Aufhäuser Fund Services S.A. will act as the Alternative Investment Fund Manager. The ECFB will provide access to equity, debt or...

ImCheck Therapeutics SAS raises €48m
The €48m financing was co-led by Pfizer Ventures, the venture capital arm of Pfizer Inc., and Bpifrance, with the new investors Wellington Partners,...